Cash flows from operating activities: | |
Net income | 12.9M |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Depreciation | 100.54M |
Amortization of intangible assets | 21.28M |
Deferred income taxes | 3.43M |
Stock-based compensation expense | 25.42M |
Loss on disposition of fixed assets | 17.81M |
Other non-cash adjustments | |
Increase (decrease) in cash resulting from changes in operating assets and liabilities | |
Accounts receivable | 6.49M |
Inventories | -2.07M |
Other assets | -5.91M |
Accounts payable | -8.88M |
Accrued liabilities | 13.4M |
Other liabilities | 2.32M |
Net cash provided by operating activities | |
Cash flows from investing activities: | |
Purchase of property, equipment and satellites, net | -260.03M |
Cash paid for patents, licenses and other assets | -38.43M |
Net cash used in investing activities | |
Cash flows from financing activities: | |
Proceeds from line of credit borrowings | 90M |
Payments on line of credit | -45M |
Proceeds from issuance of common stock under equity plans | 14.49M |
Purchase of common stock in treasury | |
Net cash provided by (used in) financing activities | |
Effect of exchange rate changes on cash | |
Net increase (decrease) in cash and cash equivalents | 9.19M |
Cash and cash equivalents at beginning of period | 42.09M |
Cash and cash equivalents at end of period | 51.28M |
Non-cash investing and financing activities: | |
Issuance of common stock in satisfaction of certain accrued employee compensation liabilities |